1 / 5

Procurement &supply chain management

Procurement &supply chain management. 5 th Joint International Monitoring Mission. Overall observations . Increased funding for procurement of anti-TB drugs; No stock outs of anti-TB drugs & lab reagents;

tricia
Download Presentation

Procurement &supply chain management

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Procurement &supply chain management 5th Joint International Monitoring Mission

  2. Overall observations • Increased funding for procurement of anti-TB drugs; • No stock outs of anti-TB drugs & lab reagents; • Availability and use of anti-TB fixed dosage combination drugs (FDCs) increased since 2007; • Well established Pharmacovigilliance system; • Ancillary drugs available for management of ADRs; • Functioning drug distribution system; • Good storage practices 5th Joint International Monitoring Mission

  3. Challenges • Fragmented procurement: NHSO, SSO, CSMBS, BTB (GF), hospitals – higher cost, un-assured quality, frequent delays; • Numerous formulations/strengths procured: complicates drug management, leads to errors, stock outsand oversupply; • Still limited use of FDCs: poor treatment adherence and unfavorable outcomes; • Lack of pediatric anti-TB formulations; • OTC dispensing of anti-TB drugs: irrational use & amplification of resistance; • Large amount of drugs issued to MDR TB patient at once: amplify resistance & cause serious toxicity 5th Joint International Monitoring Mission

  4. 1 MONTH MDR TB PATIENT TREATMENT 5th Joint International Monitoring Mission

  5. Recommendations • Single & streamlined procurement of quality assured anti-TB medicines; • Limit procurement of anti-TB medicines to essential formulations & strengths; • Procure & promote use of fixed dosage combination drugs through all stakeholders & partners; • Procure & avail nationwide child-friendly fixed dosage anti-TB formulations; • Ban OTC dispensing of anti-TB medicines through legal sanctions; • Ensure treatment enabler or observer for M/XDR TB patients 5th Joint International Monitoring Mission

More Related